IN THE NEWS: Hear from our Chief Scientific Officer, Ranga Sarangarajan, Ph.D., in response to the question: “What key indicators do you look at to predict the future of this industry?” Full Pharma's Almanac article here: bit.ly/3enptne #metabolomics #multiomics #omics

We are attending the ASHG 2022 Annual Meeting in LA from Oct 25-29. Hear from Kari Wong, our Associate Director of Scientific Strategy, & join us @ booth #1513 to learn more about #metabolomics as a powerful tool to enhance #multiomic research: bit.ly/3gfVrT5

A crazy amount of molecular diversity arriving from Cayman Chemical today for #METLIN, this is just 6 examples of the 207 molecular standards that just arrived. Thank you Cayman helping to continue to build on 870K METLIN nature.com/articles/s4159… Nature Methods

NEWS: Metabolon Advances the Understanding of Inflammation and Inflammatory Response with New Oxysterols Targeted Panel. The new targeted panel provides absolute quantitation for important bioactive intermediaries of inflammation and disease pathogenesis: bit.ly/3sw4zWB

Really excited about this workshop titled 'BRINGING METABOLOMICS INTO THE HOME' which will discuss sampling blood away from the clinic for metabolomics applications and arranged by MetabolomicsANA. Register at us06web.zoom.us/meeting/regist…

We have a great line up of academic and industry speakers.

BEHIND THE SCENES: Meet Deirdre Hauser, Principal Research Scientist at Metabolon, and the brains behind the team responsible for the design and validation of our new #Oxysterols Targeted Panel for routine oxysterol quantification in human plasma samples: bit.ly/3Fv3WEq

Nice paper further supporting our knowledge of microbiome-blood metabolite associations rdcu.be/cZwt8

To bring awareness to the use & misuse of #antibiotics this #USAntibioticAwarenessWeek, check out this publication-"Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatment:" bit.ly/3TUgZTp

Steve Rudden Elon Musk No. Being the principal owner of Twitter and running Twitter as CEO are entirely different matters. If he gives up running TWTR, Elon can focus on $TSLA, and there is far less chance of permanent brand risk at TSLA.

Calling all #metabolomics researchers! Take our State of Metabolomics #survey: mtbln.co/survey-2023. All results will inform a State of Metabolomics 2023 report to explore the capabilities, limitations, & future potential of metabolomics in basic & applied #research settings.

Doing nutritional research? Don’t miss this talk by Dr Alessandro Busetti showcasing how metabolomics can take your research to the next level with #metabolomics. #nutrition #supplementation #personalizednutrition #whatsnext

Downloadable #METLIN-CCS library @NatureMethods just released 185K CCS values on 27,633 molecular stds. Multiple ion types MH+, MNa+, M–H, dimers pos/neg ioniz., not a bad #AI resource. Great collaboration w Biemann laureate Dr. Erin Baker @ASMSnews nature.com/articles/s4159…

NEWS: Metabolon Collaborates with Trajan on Microsampling Solutions for Metabolomics Research. Read here: bit.ly/3G5QuGb #metabolomics #microsampling #collaboration #multiomics #omics #biotech #biomarkers #phenotype #phenotyping #bloodcollection

📣 Exciting News! #Metabolon is pleased to announce the launch of our NEW Integrated #Bioinformatics Platform! Dive into the world of #metabolomics with ease and precision with our cutting-edge platform! 👉 Learn more: mtbln.co/5qwi97

🧠 🧬A new paper from Harvard Medical School using Metabolon's data links gut-derived metabolites, especially from the tryptophan pathway, to Multiple Sclerosis inflammation via AHR receptor signaling - unlocking potential new therapeutic targets. mtbln.co/cg3ozu #Metabolomics

Metabolon is attending #ASMS2025! And you? If so, visit poster #560 on Tuesday, where Richard Robinson will present: “Building Biologically Relevant Libraries: How Comprehensive Libraries and Deep MS/MS Coverage Enable Intelligent Library Growth.” #MassSpectrometry"